It's Time for Hospitals to Put Patients First


By Sally C. Pipes


Many hospitals are refusing to comply with a Trump-era requirement that went into effect on January 1st of this year to publish the prices for more than 300 "shoppable" medical procedures.


This intransigence is alarming -- and expensive. The rule could save American patients and insurers up to $27 billion annually, but only if hospitals play ball.


Rates of noncompliance are extraordinarily high. Three-quarters of the highest-earning hospitals in the country aren't fully compliant with the rule, according to researchers at Harvard Medical School. A March analysis found that two-thirds of hospitals weren't complying.


When hospitals don't publish their prices, patients have no way of knowing if they're getting a good deal on elective surgeries and other procedures -- or getting ripped off.


Prices for identical services vary widely, depending on the location and provider. Even in the same city, there are major price discrepancies. The most expensive 5% of hospitals in metro areas containing over 3 million people receive almost $1,400 for each knee MRI, on average. The least expensive 5% of hospitals in those metro areas take in just $600 for the scan, according to Crowe, a consulting firm.


If a gas station or grocery store tried to slap a 133% premium on an identical product, they wouldn't get much business. Customers shopping for gas or food can easily compare prices and find a more competitive option.


That's why hospitals are so loathe to comply with the rule -- the lack of transparency makes it much easier to gouge patients and insurers.


Hospital groups have already lost two court challenges against the rule. Their attorneys claimed that patients would be unable to decipher byzantine pricing schedules and could not be trusted to make responsible financial and health decisions. They complained that publishing their prices would be an expensive regulatory burden.


But consumers make weighty financial and health decisions all the time. Transparent prices make that task easier, not harder.


Perhaps the best example is Lasik eye surgery. Because the procedure is optional, many insurers don't cover it. Patients must pay out of pocket. That incentivizes them to shop around and compare different providers.


It's no coincidence that Lasik has gotten cheaper since the turn of the century in inflation-adjusted dollars, while virtually every other hospital procedure has gotten dramatically more expensive.


The notion that publishing prices is some gargantuan regulatory burden is ridiculous. The Centers for Medicare and Medicaid Services estimates that the direct cost to hospitals in the first year would be around $12,000 -- far less than a single administrative worker's full-time salary, and a drop in the bucket for hospitals that bring in tens of millions of dollars each year.


The fight to make health care more affordable and accessible for ordinary Americans begins with price transparency. It's long past time for hospitals to publish their prices -- so that market competition can drive down costs and improve quality.


Sally C. Pipes is President, CEO, and Thomas W. Smith Fellow in Health Care Policy at the Pacific Research Institute. Her latest book is False Premise, False Promise: The Disastrous Reality of Medicare for All (Encounter 2020). Follow her on Twitter @sallypipes.

More Resources


11/22/2024
Mighty Casey Has Struck Out
Democrat Bob Casey Jr. has served in public office in this state since taking the oath of office as the state auditor general in 1997.

more info


11/22/2024
Gaetz's Implosion Shows Resistance Is Not Futile
Trump's first nominations reveal the serious fractures in his coalition - which can be used to weaken him

more info


11/22/2024
Building a Better Ground Game Critical to Trump's Victory
American Majority Action turned out low-participation voters in battleground States to help Trump and fellow Republicans to victory.

more info


11/22/2024
The Myth That Could Cost Democrats the Next Election
Progressives staying home (almost certainly) didn't cost Kamala Harris the election.

more info


11/22/2024
Jussie Smollett, the Chicago Way and MAGA


more info


11/22/2024
It's Over--Somebody Needs To Tell Bragg's Office


more info


11/22/2024
Congress Must Seize Post-Chevron Opportunity


more info


11/22/2024
Former NIH Director Francis Collins on Trump, RFK Jr.


more info


11/22/2024
How the Left Betrayed the Jews


more info


11/22/2024
I Mean, Seriously Jaguar?
In the aftermath of Trump's victory, the ad already looks like a period piece. But aside from that - I mean, seriously? says Guardian columnist Marina Hyde

more info


11/22/2024
November 22, 1963: JFK and the Futility of Blame


more info


11/22/2024
Dems Have Lost the Plot in the View of Working-Class Voters
The road back to the working class.

more info


11/22/2024
The Trump Counterrevolution Is a Return to Sanity
We are witnessing a historic counterrevolution after Trump's victory, far different from his first election in 2016.

more info


11/22/2024
Harris Disappointed Gen Z
Trump made gains among young voters in 2024, leaving Democrats wondering why.

more info


11/22/2024
Democrats Need Their Own Donald Trump
There may be five stages of grief, but there's usually just one when it comes to political defeat - pretend to soul-search, then carry on as if nothing happened.

more info



Custom Search

More Politics Articles:

Related Articles

Congress: Let's Talk About Trade Enforcement


The Trump administration has set an ambitious trade agenda for the remainder of 2020. In a House Ways and Means Committee hearing earlier this summer, U.S. Trade Representative Robert Lighthizer stressed the president's intent to crack down on foreign countries that discriminate against American business and innovators.

With Biomedical Research, Taxpayers are Getting a Great Deal


Gilead Sciences' novel drug remdesivir has shown immense promise for treating coronavirus. Yet every time a company develops a promising drug, some policymakers call for the government to take control of the compound in question.

Marx on Christianity, Judaism, and Evolution/Race


"If someone calls it socialism," said the Rev. William Barber at an August 2019 conference of the Democratic National Committee, "then we must compel them to acknowledge that the Bible must then promote socialism, because Jesus offered free health care to everyone, and he never charged a leper a co-pay."

Abusing March-in Rights Would Jeopardize COVID-19 Research


Thirty-one state attorneys general recently urged the Trump administration to disregard the intellectual property protections on remdesivir -- the only FDA-approved treatment for COVID-19 -- and then license its patents to multiple drug manufacturers.

Judge Amy Coney Barrett and the Purdue Sexual Assault Case


Will some senators on the Senate Judiciary Committee vilify Judge Amy Coney Barrett, President Trump's Supreme Court nominee? Attacks on her religion, her large family, or claims that she will block the advance of women may make good fodder for Facebook, but senators who pursue those tacks are likely to reap public disapproval from their own constituents. What is more likely is that liberal senators will take a page from liberal/progressive organizations like Public Justice and portray Barrett as soft on and complicit with campus sexual abusers. How?

President Trump's Executive Order Will Put an End to Pharmaceutical Breakthroughs


Every day, scientists get closer to a COVID-19 vaccine. A handful of biopharmaceutical firms hope to make one available by year's end.

The Mayflower Mystique: Remembering the Pilgrims


Few can name which groups the Godspeed and the Arabella brought to America. They were the Jamestown colonists in 1607 and the Puritans to Massachusetts Bay Colony in 1630, respectively. But the Mayflower, which brought the Pilgrims to Plymouth in 1620, has sailed into history and ranks with the Titanic, the Lusitania, the Bismarck, and the Queen Mary as the world’s most famous ships. What accounts for the Mayflower’s mystique?

COVID's Second Wave Underscores the Threats Facing Disabled Americans


The second wave of COVID-19 has arrived with a vengeance.

Triumph of the Vaccine—No Shape-Shifting Enemy


Here’s a thought experiment. What if our experience with COVID-19 turns out to be a warm-up for responding to a worse plague in the future? COVID-19 is devastating for a significant number of older people but relatively innocuous for the young. I am thankful that this is not like the Justinian plague, nor the Athenian one, nor like smallpox. What if—God forbid—we find ourselves hosting a plague like one of these? Something as deadly as Ebola but as infectious as SARS-CoV-2?

Who is Perfect? Biden, Trump, McConnell, Pelosi?


Democrats have proven once again that they can find fault in President Donald Trump. Faults and flaws were found in him before the election. Many years before politics there were never any rave reviews about him being perfect.

The 340B Prescription-Drug Swindle Has Gone on Long Enough


In a recent hearing, California Attorney General Xavier Becerra revealed just how unfit he is to lead the Department of Health and Human Services.

Vaccination is the Ticket to Getting the U.S. Back On Track


The end of the pandemic in the U.S. is in sight. The Covid-19 vaccines currently available in the United States have proven to be outstandingly effective at protecting recipients from coronavirus and they are also safe.

Private Deborah Sampson, 'The Female Soldier'


There are those who would say that Private Deborah Sampson deserved the Medal of Honor, but she didn’t sign up for that; she joined the Army to fight for her country and wound up making history. Private Sampson was America’s first woman combat soldier. She served, disguised as a man by the name of Robert Shurtleff, under the command of General George Washington in the Continental Army during the American Revolution.

The End of Covid-19 Could Start in the Hair Salon


President Biden has floated an ambitious goal -- vaccinate enough Americans to achieve some sense of normalcy by July 4.

President Biden Is Right to Redefine Infrastructure


President Biden is in ongoing talks to discuss his multi-trillion-dollar infrastructure plan. Ever since its release, critics have claimed that many aspects of the plan have nothing to do with infrastructure.

America Needs Strong Patent Laws to Keep Inventing


In May, the Biden administration announced its support for a proposal at the World Trade Organization to suspend international intellectual property protections on Covid-19 vaccines.